An anticancer drug in which hu14.18, a monoclonal antibody, is combined with interleukin-2. The monoclonal antibody binds to the cancer cells and delivers IL-2, which stimulates the immune system to destroy the cancer cells.
HU14.18-INTERLEUKIN-2 FUSION PROTEIN
Meaning of HU14.18-INTERLEUKIN-2 FUSION PROTEIN in English
NCI English Dictionary of Cancer Terms. Английский словарь раковых терминов NCI(Национальный институт злокачественных новообразований). 2012